Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) – Analysts at HC Wainwright lifted their FY2022 earnings estimates for Context Therapeutics in a research report issued to clients and investors on Thursday, November 10th. HC Wainwright analyst E. Bodnar now expects that the company will earn ($0.97) per share for the year, up from their previous […]